Recent News

• 11.05.2026 - HiFi long-read sequencing highlights from ASHG 2026
• 11.04.2026 - PacBio Announces Third Quarter 2026 Financial Results
• 10.29.2026 - Sequencing 101: HiFi long-read analysis for clinical research workflows
• 10.27.2026 - PacBio to Participate in Upcoming Investor Conferences
• 10.27.2026 - Recent epi-C publications from our users
• 10.22.2026 - How certified service providers expand access to HiFi sequencing with SPRQ-Nx chemistry
• 10.19.2026 - PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI
• 10.15.2026 - New opportunities to streamline targeted sequencing workflows with PureTarget
• 10.14.2026 - PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026
• 10.08.2026 - Harnessing the Kivvi tool to resolve the genetics of FSHD with HiFi sequencing

Recent Filings

• 11.06.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.04.2026 - 8-K Current report
• 11.04.2026 - EX-99.1 EX-99.1
• 10.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.06.2026 - 144 Report of proposed sale of securities
• 08.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.17.2026 - 144 Report of proposed sale of securities
• 08.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2026 - 4 Statement of changes in beneficial ownership of securities